India·Source-based summary
CSIR-CCMB develops India-specific tool topredict Sickle Cell severity
The new tool could improve treatment decisions and disease management as existing international scoring systems do not accurately reflect the clinical profile of Indian patients with SCA
This is a source-based summary, not original reporting by Ebenezer journalists. Source: The Hindu. Ebenezer published 2 Oct 2026, 12:17 pm. Editorial policy.
Read the original report on The Hindu →
India — The Hindu

